San Diego, CA, United States of America

Martin Keller

USPTO Granted Patents = 22 



Average Co-Inventor Count = 1.9

ph-index = 8

Forward Citations = 324(Granted Patents)


Location History:

  • Golden, CO (US) (1978 - 1999)
  • San Diego, CA (US) (2001 - 2005)
  • Fairfax, VA (US) (2012)
  • Toledo, OH (US) (2012)
  • Indian Trail, NC (US) (2015)
  • Kill Devil Hills, NC (US) (2017)
  • Knoxville, TN (US) (2016 - 2023)

Company Filing History:


Years Active: 1978-2025

Loading Chart...
Loading Chart...
Loading Chart...
22 patents (USPTO):Explore Patents

As an AI assistant specializing in innovations, inventions, inventors, patent attorneys, assignees, and patents, I'll write an article about the inventor Martin Keller for your website idiyas.com.

Title: Unveiling the Innovations of Inventor Martin Keller from San Diego, CA

Introduction: Meet Martin Keller, a brilliant inventor hailing from San Diego, CA, known for his remarkable contributions to the field of biotechnology and enzyme screening.

Latest Patents:

1. Capillary Array-based Enzyme Screening: Martin Keller's patented process revolutionizes enzyme screening by utilizing capillaries to identify clones expressing enzymes with desired activities. This innovative method streamlines the screening process, enabling the identification of signal-producing clones efficiently.

2. High Throughput Screening for Novel Bioactivities: Another groundbreaking patent by Martin Keller focuses on identifying clones with specified activities by generating expression libraries from nucleic acids isolated from the environment. The process involves screening these libraries with a fluorescence-activated cell sorter to pinpoint clones with the desired bioactivities.

Career Highlights: Martin Keller is a key figure at Diversa Corporation, where his inventive spirit has led to the development of cutting-edge technologies in enzyme screening and bioactivity identification. With a total of 8 patents to his name, Martin Keller continues to drive innovation in the biotechnology sector.

Collaborations: In his journey of innovation, Martin Keller has collaborated with esteemed colleagues such as Jay Milton Short and William Michael Lafferty. Together, they have pushed the boundaries of biotechnology and made significant advancements in enzyme screening methodologies.

Conclusion: Inventor Martin Keller's pioneering work in enzyme screening and bioactivity identification showcases his dedication to advancing the field of biotechnology. His patents stand as a testament to his creativity, ingenuity, and commitment to driving innovations that shape the future of scientific research.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…